SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Lupus/Nephritis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (67)11/23/2005 7:41:04 PM
From: John McCarthy   of 95
 
Statement from Sandra C. Raymond, President and CEO of the Lupus Foundation of America, Inc., Regarding the Landmark Lupus Study Published in the November 24, 2005 Issue of the New England Journal of Medicine

WASHINGTON, Nov. 23 /PRNewswire/ -- "We applaud the results of a research study on the effectiveness of mycophenolate mofetil (MMF) as a potential new
treatment for lupus nephritis (lupus kidney disease) which are published inthe November 24, 2005 issue of the New England Journal of Medicine. The multi-center clinical study found that MMF, or CellCept(R), was more effective
than the current standard-of-treatment with intravenous cyclophosphamide, and had a better safety profile.

CellCept holds the promise of a better quality of life for people with lupus who suffer the debilitating effects of severe lupus kidney disease.

Current chemotherapy drugs used to treat lupus nephritis have potentially serious and life threatening side effects that can be worse than the primary disease. It has been more than 30 years since the FDA has approved a new therapy for lupus.

The results of this study are encouraging and offer hope that doctors soon will have a safer and more effective treatment alternative that has fewer side
effects typically associated with currently-available treatments. Doctors and their lupus patients eagerly await approval of CellCept as a new treatment that will bring lupus under control and allow those affected to look forward
to a healthier future."

prnewswire.com

About CellCept ... (I assume this is the
product they are talking about)

rocheusa.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News